Claudin18.2 (CLDN18.2) expression and efficacy in pancreatic ductal adenocarcinoma (PDAC): Results from a phase I dose expansion cohort evaluating IBI343. 10-year follow up of a phase 2 clinical trial ...

EBC-129 has been granted FDA fast track designation for the treatment of pancreatic ductal adenocarcinoma, paving the way for ...

US FDA grants fast track designation to EDDC’s antibody-drug conjugate EBC-129 to treat pancreatic ductal adenocarcinoma: Singapore Thursday, May 29, 2025, 12:00 Hrs [IST] The E ...

The following is a summary of “Comparing the impacts of different exercise interventions on patients with type 2 diabetes ...

It selectively targets a tumour-specific N-glycosylated epitope on both CEACAM5 and CEACAM6. The Fast Track Designation highlights the potential of EBC-129 to address critical unmet needs in ...

A study by researchers at the Interuniversity Institute of Bioinformatics in Brussels, the Structural Biology research group at Vrije Universiteit Brussel, and IBiTech–BioMMedA Group of Ghent ...

From boosting immunity to improving blood flow and pressure, beetroot is said to possess many health benefits. It is often ...

Bananas, particularly in their green or unripe form, provide significant digestive and metabolic benefits, primarily due to their high levels of resistant starch and glycosylated polyphenols ...

The insulin, interferon, and recombinant non-glycosylated protein biosimilars segment is also forecasted to grow at a 12.8% CAGR from 2023 to 2032. Leading pharmaceutical and biotech companies ...

A new study published in Nature Structural and Molecular Biology offers groundbreaking evidence that gut bacteria can ...

Blocking this pathway addresses the root cause of IgAN by diminishing the production of the aberrantly glycosylated IgA1 that initiates the disease process. Clinical significance: The VISIONARY ...